ONTO INNOVATION INC.
Ticker: ONTOHealthcareMedical InstrumentsThe business
Onto Innovation Inc. (NASDAQ: ONTO) is a worldwide leader in the design, development, manufacture and support of metrology and inspection tools for the semiconductor industry. The company's website is located at http://www.ontoinnovation.com.
The company provides process control and yield management solutions used across semiconductor manufacturing, serving silicon wafer manufacturers, integrated circuit fabricators, and advanced packaging manufacturers. Onto Innovation's product portfolio spans optical metrology systems, macro defect inspection tools, advanced packaging lithography systems, and process control analytical software. The company's automated metrology systems include the Atlas family for optical critical dimension and thin film metrology, while integrated metrology systems such as the IMPULSE family are installed directly onto wafer processing equipment. For macro defect inspection, Onto Innovation offers tools including the F30, NSX, Firefly, and Dragonfly G3 systems. The company's lithography offerings include the JetStep X500 system designed for rectangular panel substrates used in advanced packaging applications.
In the fourth quarter of 2025, Onto Innovation acquired Semilab USA, adding three advanced product lines—FAaST, CnCV, and MBIR—that enhance capabilities in inline wafer contamination monitoring, materials characterization, and surface charge metrology. The company also maintains a 4D Technology business offering interferometry systems for precision surface measurement in aerospace, defense, and scientific research applications.
Onto Innovation serves over 190 customers across more than 25 countries. As of January 3, 2026, the company employed approximately 1,615 staff globally, with 55 percent located in the United States, 40 percent in Asia Pacific, and 5 percent in Europe. The company maintains manufacturing operations in Milpitas, California; Tucson, Arizona; Wilmington, Massachusetts; Bloomington, Minnesota; and through various contract manufacturers worldwide. Onto Innovation holds or exclusively licenses 423 U.S. and foreign patents with expiration dates ranging from 2026 to 2044, with an additional 312 pending patent applications covering metrology, defect detection, lithography techniques, and artificial intelligence technologies.
- Sector
- Healthcare
- Industry
- Medical Instruments
- HQ
- WILMINGTON, MA
- FY end
- 12-26
- CIK
- 704532
- SIC
- 3829
Ownership
Who holds ONTO INNOVATION INC. — across funds, superinvestors and bonds · N-PORT 2026Q2 · 13F 2026-06-30
Top fund holders
| Fund | % of fund | Value |
|---|---|---|
| iShares Core S&P Mid-Cap ETF IJH · iShares Trust | 0.52% | $644.27M |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VTI · VANGUARD INDEX FUNDS | 0.03% | $598.05M |
| VANGUARD SMALL-CAP INDEX FUND VB · VANGUARD INDEX FUNDS | 0.23% | $431.67M |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VBK · VANGUARD INDEX FUNDS | 0.53% | $248.96M |
| VANGUARD EXTENDED MARKET INDEX FUND VXF · VANGUARD INDEX FUNDS | 0.22% | $215.83M |
Bonds held by funds
Funds report holding 1 issues of ONTO INNOVATION INC.'s debt, $95.32M at fund-held market value — what funds hold, not the company's debt outstanding.
| Issue | Coupon | Matures | Funds | Fund-held |
|---|---|---|---|---|
| Onto Innovation Inc | 0.000%None | 2031-06-01 | 40 | $95.32M |
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Go deeper in your own AI
15 years of statements, narrative and filings — queryable over MCP.
Professionals can also use the built-in AI chat (subscription + your own Anthropic key).
15 years of ONTO INNOVATION INC.'s financials
Income statement, balance sheet and cash flow across 15 years, every filing with its disclosures, and each number traceable to the filing it came from — free with an account, no card required.
Sign in free